| 000 | 01629 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513100420.0 | ||
| 264 | 0 | _c19960927 | |
| 008 | 199609s 0 0 eng d | ||
| 022 | _a0340-6199 | ||
| 024 | 7 |
_a10.1007/BF01958642 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLenney, W | |
| 245 | 0 | 0 |
_aEfficacy and safety of salmeterol in childhood asthma. _h[electronic resource] |
| 260 |
_bEuropean journal of pediatrics _cDec 1995 |
||
| 300 |
_a983-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xpharmacology |
| 650 | 0 | 4 |
_aAlbuterol _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedical Records |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 | _aPeak Expiratory Flow Rate |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSalmeterol Xinafoate |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aPedersen, S | |
| 700 | 1 | _aBoner, A L | |
| 700 | 1 | _aEbbutt, A | |
| 700 | 1 | _aJenkins, M M | |
| 773 | 0 |
_tEuropean journal of pediatrics _gvol. 154 _gno. 12 _gp. 983-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01958642 _zAvailable from publisher's website |
| 999 |
_c8797398 _d8797398 |
||